NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 22, 2025 — Strawberry Fields REIT acquires 18th Missouri facility for $5.3M, adding 124 healthcare beds. The NYSE AMERICAN: STRW REIT now operates 142 facilities across 10 states amid growing senior care demand.
September 22, 2025 — Researchers discover circular DNA fragments drive glioblastoma's lethality, challenging cancer treatment paradigms. CNS Pharmaceuticals explores new therapies based on these rogue genetic elements.
September 22, 2025 — Oncotelic Therapeutics CEO discusses cancer treatment milestones in BioMedWire podcast. Learn about upcoming IND approvals, partnership announcements, and the company's innovative oncology pipeline.
September 22, 2025 — HeartBeam's FDA-cleared 3D ECG system transforms at-home cardiac monitoring with cable-free technology that captures heart signals from three angles for improved arrhythmia detection.
September 22, 2025 — GeoVax reaffirms commitment to vaccine safety as GEO-CM04S1 COVID-19 vaccine advances for immunocompromised patients. MVA platform shows promising safety profile in Phase 2 trials.
September 22, 2025 — Dr. Daniel Lackland of MUSC wins American Heart Association's 2025 Population Research Prize for groundbreaking hypertension and stroke prevention research addressing health disparities.
September 22, 2025 — American Heart Association & NFL award Super Bowl tickets to students who learned CPR. Five schools win $10,000 equipment grants. Initiative aims to boost cardiac arrest survival rates through youth education.
September 22, 2025 — Maryland hospitals saw 5% more medical mistakes in 2023. Language barriers among foreign-born staff may contribute to communication errors affecting patient safety and care quality.
September 22, 2025 — AHA report: 33-50% of heart attack survivors face depression, anxiety, or PTSD, raising cardiac event risks. Learn treatments and why mental health is key to recovery.
September 22, 2025 — Beauté Medical Aesthetics in Georgia offers expert Botox services with a focus on natural results and safety. Learn about their personalized treatments and non-surgical options.
September 21, 2025 — Alicia Kali establishes world's first Neuroscience & BioQuantum Research Institute, pioneering unified intelligence framework connecting human cognition, regenerative health & AI development.
September 20, 2025 — Bebird introduces smart visual ear cleaners revolutionizing personal ear care. Addresses earbud wax buildup, swimmer's ear risks, and hygiene concerns with smartphone-enabled inspection technology.
September 19, 2025 — Blue Sky Scrubs launches sickle cell awareness campaign during September 2025, donating scrubs proceeds to research. Features giveaways and social media engagement to support millions affected.
September 19, 2025 — Sambo Ly of Alameda Health System wins KPIX Icon Award for decades serving refugees and enhancing language access in healthcare, ensuring equitable care for all patients.
September 19, 2025 — Soligenix advances SGX942 for oral mucositis treatment in cancer patients. Clinical trials show promise for addressing this debilitating side effect with no FDA-approved solutions currently available.
September 19, 2025 — Nutriband Inc. secures FDA meeting for AVERSA abuse-deterrent fentanyl patch technology, addressing opioid crisis through innovative transdermal pharmaceutical development.
September 19, 2025 — Oncotelic Therapeutics advances OT-101 Phase 3 pancreatic cancer treatment under CEO Dr. Vuong Trieu, inventor of Abraxane. Late-stage pipeline targets high-unmet-need oncology indications.
September 19, 2025 — UCLA Health receives $2M grant from ViewRay Systems to research MRI-guided radiation therapy for targeted cancer treatment, advancing precision medicine.
September 19, 2025 — Izotropic Corporation raises $375,000 in private placement to fund development of advanced breast cancer imaging technology for improved screening and diagnosis accuracy.
September 19, 2025 — Oncotelic Therapeutics advances innovative oncology pipeline under CEO Dr. Vuong Trieu, featuring groundbreaking cancer treatments and rare disease therapies with strong market potential.